|
|
|
Volumn 112, Issue 7, 2008, Pages 590-600
|
|
Pegaptanib sodium one-year treatment study for neovascular age-related macular degeneration
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APTAMER;
PEGAPTANIB;
VASCULOTROPIN A;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
INJECTION;
MALE;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
RETINA MACULA DEGENERATION;
SUBRETINAL NEOVASCULARIZATION;
VISUAL ACUITY;
VITREOUS BODY;
AGED;
APTAMERS, NUCLEOTIDE;
CHOROIDAL NEOVASCULARIZATION;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INJECTIONS;
MACULAR DEGENERATION;
MALE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITREOUS BODY;
|
|
EID: 52449119549
PISSN: 00290203
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
